These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33965490)

  • 1. ATP/Hyals dually responsive core-shell hyaluronan/chitosan-based drug nanocarrier for potential application in breast cancer therapy.
    Li H; Zhuang S; Yang Y; Zhou F; Rong J; Zhao J
    Int J Biol Macromol; 2021 Jul; 183():839-851. PubMed ID: 33965490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A core/shell stabilized polysaccharide-based nanoparticle with intracellular environment-sensitive drug delivery for breast cancer therapy.
    Wu Y; Zhang X; Li H; Deng P; Li H; He T; Rong J; Zhao J; Liu Z
    J Mater Chem B; 2018 Nov; 6(41):6646-6659. PubMed ID: 32254873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
    Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
    Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells.
    Dashti N; Akbari V; Varshosaz J; Soleimanbeigi M; Rostami M
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):131971. PubMed ID: 38705336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy.
    Zhou H; Fan Z; Deng J; Lemons PK; Arhontoulis DC; Bowne WB; Cheng H
    Nano Lett; 2016 May; 16(5):3268-77. PubMed ID: 27057591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
    Yang H; Tang C; Yin C
    Acta Biomater; 2018 Jun; 73():400-411. PubMed ID: 29660508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
    Haque ST; Islam RA; Gan SH; Chowdhury EH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
    [No Abstract]   [Full Text] [Related]  

  • 11. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan.
    Qiao F; Jiang Z; Fang W; Sun J; Hu Q
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
    Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-responsive nanoparticles based on chitosan for enhanced breast cancer therapy.
    Zhang X; Niu S; Williams GR; Wu J; Chen X; Zheng H; Zhu LM
    Carbohydr Polym; 2019 Oct; 221():84-93. PubMed ID: 31227170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simply constructed chitosan nanocarriers with precise spatiotemporal control for efficient intracellular drug delivery.
    Kong M; Zuo Y; Wang M; Bai X; Feng C; Chen X
    Carbohydr Polym; 2017 Aug; 169():341-350. PubMed ID: 28504154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of quercetin-loaded hyaluronic acid-conjugated pH/redox dual-stimuli responsive poly(methacrylic acid)/mesoporous organosilica nanoparticles for breast cancer targeted therapy.
    Ghalehkhondabi V; Soleymani M; Fazlali A
    Int J Biol Macromol; 2024 Apr; 263(Pt 1):130168. PubMed ID: 38365162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies.
    Liu HN; Guo NN; Wang TT; Guo WW; Lin MT; Huang-Fu MY; Vakili MR; Xu WH; Chen JJ; Wei QC; Han M; Lavasanifar A; Gao JQ
    Mol Pharm; 2018 Mar; 15(3):882-891. PubMed ID: 29357260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
    Rajan M; Raj V; Al-Arfaj AA; Murugan AM
    Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.